Login / Register Submit Your Article
cover
Article Menu

Journal Browser
Vol. 6 (2024)
Vol. 5 (2023)
Vol. 4 (2022)
Vol. 3 (2021)
Vol. 2 (2020)
Vol. 1 (2019)
Open Access Journal Article

Artificial Intelligence in Drug Discovery and Development

by Olivia Martin 1,*
1
Olivia Martin
*
Author to whom correspondence should be addressed.
as  2021, 21; 3(2), 21; https://doi.org/10.69610/j.as.20210822
Received: 18 June 2021 / Accepted: 15 July 2021 / Published Online: 22 August 2021
View Full-Text
Download PDF

Abstract

The integration of artificial intelligence (AI) into the drug discovery and development process has revolutionized the pharmaceutical industry, offering unprecedented efficiency and precision. This abstract explores the multifaceted impact of AI on drug discovery, including the application of machine learning algorithms to identify potential drug targets, optimize compound design, and streamline preclinical and clinical trials. AI-driven computational tools enable the analysis of vast amounts of biological and chemical data, leading to the identification of novel drug candidates with higher success rates. Furthermore, this summary delves into how AI facilitates the acceleration of drug development timelines by predicting drug efficacy and safety, thereby reducing costs and time-to-market. The challenges and ethical considerations in utilizing AI for drug discovery are also addressed, emphasizing the need for rigorous validation and transparency in AI-based drug development processes.

Keywords: Artificial Intelligence, Drug Discovery, Machine Learning, Computational Biology, Drug Development Efficiency.;
Copyright: © 2021 by Martin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (Creative Commons Attribution 4.0 International License). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Share and Cite

ACS Style
Martin, O. Artificial Intelligence in Drug Discovery and Development. Advanced Sciences, 2021, 3, 21. https://doi.org/10.69610/j.as.20210822
AMA Style
Martin O. Artificial Intelligence in Drug Discovery and Development. Advanced Sciences; 2021, 3(2):21. https://doi.org/10.69610/j.as.20210822
Chicago/Turabian Style
Martin, Olivia 2021. "Artificial Intelligence in Drug Discovery and Development" Advanced Sciences 3, no.2:21. https://doi.org/10.69610/j.as.20210822
APA style
Martin, O. (2021). Artificial Intelligence in Drug Discovery and Development. Advanced Sciences, 3(2), 21. https://doi.org/10.69610/j.as.20210822

Article Metrics

Article Access Statistics

References

  1. Burbules, N. C., & Callister, T. A. (2000). Watch IT: The Risks and Promises of Information Technologies for Education. Westview Press.
  2. Liu, L., Li, Y., Niu, B., & Wang, Y. (2017). Deep learning for drug target identification. Journal of Chemical Information and Modeling, 57(2), 410-417.
  3. Goldfeder, S., Wang, F., & Zang, X. (2017). AI predicts protein-protein interactions. Nature Biotechnology, 35(10), 923-925.
  4. Meijaard, K., Furr, J. R., Feo, M. A., & prediction of ADME properties. Journal of Chemical Information and Modeling, 57(12), 2942-2954.
  5. Tkachenko, A., Mitra, N., & Koes, R. D. (2018). Deep learning for structure-based drug design: successes, progress, and perspectives. Drug Discovery Today, 23(1), 185-198.
  6. FDA (2019). Artificial Intelligence and Machine Learning: A FDA Perspective. U.S. Food and Drug Administration.
  7. Jha, A., Chen, P. H., & Kalpathy-Cramer, J. (2018). Artificial intelligence in radiology: towards the next revolution. Nature Biotechnology, 36(3), 243-252.
  8. Di, L., Wang, Y., & Liu, L. (2018). Artificial intelligence for personalized medicine in oncology. Nature Reviews Clinical Oncology, 15(1), 5-18.
  9. Pei, Y., Wang, S., & Liu, L. (2017). AI predicts the toxicology profiles of drug candidates. Journal of Chemical Information and Modeling, 57(12), 3072-3078.
  10. Wu, C., Yang, L., & Liu, L. (2019). AI optimizes clinical trial designs. Nature Biotechnology, 37(7), 819-821.
  11. O'Hara, K. J., Szalavari, Z., Breuer, D., & Poger, G. (2018). Ethical considerations in AI-driven drug discovery. Nature Biotechnology, 36(7), 615-616.